PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Policlinico Universitario \'G. Martino\', Via Consolare Valeria 1, 98125, Messina, Italy.\', \'Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, Italy.\', \'Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Policlinico Universitario \'G. Martino\', Via Consolare Valeria 1, 98125, Messina, Italy. trifirog@unime.it.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s40259-020-00430-1
?:doi
?:hasPublicationType
?:journal
  • BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
is ?:pmid of
?:pmid
?:pmid
  • 32557214
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all